Excellent LinKinvax's journey to Mexico, an event made possible thanks to Business France, French Embassy in Mexico and mexican partners.
The opportunity to present our outstanding and innovative vaccine platform, based on our proprietary DC targeting tec…https://t.co/diDZ5Z16HF
🙏🗺 Thank you @businessfrance North America for organizing this amazing #NEXTBiotechBoosterroadshow dedicated to biotech ecosystem.
👉2 days in Boston to develop new connection with the US market, meet life sciences investors and inspiring people in the healthcare sector.
🗓#ESMO22#cancer@LinKinVax se mobilise pour accélérer ses développements en oncologie.
Chaque étude, donnée présentée ici porte l’espoir des malades, rappelle à tous que les patients sont au cœur des efforts intenses de notre recherche en oncologie.
https://t.co/LW6LVsv5Sb
As the #WHO awaits the second generation of vaccines against #Covid_19 , we are proud to announce our collaboration with #GTPBioways to develop and manufacture our pan-coronavirus recall #vaccine
against SarsCoV2 and variants. #health#innovation https://t.co/hbByN5xnST
@LinKinVax et @InsermTransfert signent un accord de licence pour l'exploitation d'une plateforme vaccinale innovante basée sur les cellules dendritiques, des cellules fondamentales du système immunitaires servant à la stimulation et à la régulation des réponses immunitaires.
👏 👏 Proud to promote #research work from the VRI/INSERM and actively contribute to the development of innovative, preventive and therapeutic #vaccines for pathologies that are real public #health issues at the global level #HIV#SARSCoV2#HPV#cancer
https://t.co/JQFUiGBySZ